InsiderClue
Insiders · Profile

Sendek Joel

Chief Financial Officer at Spero Therapeutics. Filing since 6 Nov 2017. CIK 0001720875

Company
Date
Role
Action
Shares
Amount
Of holding
SPRO Spero Therapeutics, Inc.
5 Jul 2018
Chief Financial Officer
Sold, plan not stated
2,000
$35.00K
11.6%
SPRO Spero Therapeutics, Inc.
6 Nov 2017
Chief Financial Officer
Bought
5,000
$70.00K
49.1%
2 decisions on file.